XML 105 R51.htm IDEA: XBRL DOCUMENT v3.24.4
Stockholders’ Equity (Tables)
12 Months Ended
Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Plan and the Weighted Average Grant Price
A summary of the Performance, Executive, and Director Awards granted under the Stock Plan, and the weighted average grant prices, during the fiscal years ended October 31, is as follows:
202420232022
Number of SharesWeighted-Average Grant PriceNumber of SharesWeighted-Average Grant PriceNumber of SharesWeighted-Average Grant Price
Performance Awards76,236 $19.80 79,972 $13.19 — $— 
Executive Awards106,713 $17.18 193,381 $14.87 70,000 $14.96 
Director Awards27,087 $19.28 22,836 $16.26 49,231 $13.55 
Total210,036 $18.40 296,189 $14.52 119,231 $14.38 
Schedule of Nonvested Shares
A summary of the status of the Company’s nonvested shares as of October 31, 2024, and changes during fiscal year 2024, is presented below:
Number of SharesWeighted-Average
Grant Price
Nonvested at October 31, 2023314,522 $14.55 
Granted210,036 $18.40 
Vested(264,411)$15.04 
Nonvested at October 31, 2024260,147 $17.16